Suppr超能文献

加拿大导致体重增加的药物及其替代药物:一项叙述性综述

Medications that cause weight gain and alternatives in Canada: a narrative review.

作者信息

Wharton Sean, Raiber Lilian, Serodio Kristin J, Lee Jasmine, Christensen Rebecca Ag

机构信息

The Wharton Medical Clinic, Toronto, Canada,

School of Kinesiology and Health Science, York University, Toronto, Canada.

出版信息

Diabetes Metab Syndr Obes. 2018 Aug 21;11:427-438. doi: 10.2147/DMSO.S171365. eCollection 2018.

Abstract

BACKGROUND

The cause of the obesity epidemic is multifactorial, but may, in part, be related to medication-induced weight gain. While clinicians may strive to do their best to select pharmacotherapy(ies) that has the least negative impact on weight, the literature regarding the weight effects of medication is often limited and devoid of alternative therapies.

RESULTS

Antipsychotics, antidepressants, antihyperglycemics, antihypertensives and corticosteroids all contain medications that were associated with significant weight gain. However, there are several medication alternatives within the majority of these classes associated with weight neutral or even weight loss effects. Further, while not all of the classes of medication examined in this review have weight-favorable alternatives, there exist many other tools to mitigate weight gain associated with medication use, such as changes in dosing, medication delivery or the use of adjunctive therapies.

CONCLUSION

Medication-induced weight gain can be frustrating for both the patient and the clinician. As the use of pharmaceuticals continues to increase, it is pertinent for clinicians to consider the weight effects of medications prior to prescribing or in the course of treatment. In the case where it is not feasible to make changes to medication, adjunctive therapies should be considered.

摘要

背景

肥胖流行的原因是多方面的,但部分原因可能与药物引起的体重增加有关。虽然临床医生可能会尽力选择对体重负面影响最小的药物治疗方法,但关于药物对体重影响的文献往往有限,且缺乏替代疗法。

结果

抗精神病药、抗抑郁药、降糖药、抗高血压药和皮质类固醇都包含与显著体重增加相关的药物。然而,在这些药物类别中的大多数都有几种与体重中性甚至体重减轻作用相关的替代药物。此外,虽然本综述中研究的并非所有药物类别都有对体重有利的替代药物,但还有许多其他方法可以减轻与药物使用相关的体重增加,例如改变给药剂量、药物递送方式或使用辅助疗法。

结论

药物引起的体重增加对患者和临床医生来说都可能令人沮丧。随着药物使用的持续增加,临床医生在开药前或治疗过程中考虑药物对体重的影响是很有必要的。在无法改变药物的情况下,应考虑辅助疗法。

相似文献

1
Medications that cause weight gain and alternatives in Canada: a narrative review.
Diabetes Metab Syndr Obes. 2018 Aug 21;11:427-438. doi: 10.2147/DMSO.S171365. eCollection 2018.
2
Management of Medication-Induced Weight Gain.
Gastroenterol Clin North Am. 2023 Dec;52(4):751-760. doi: 10.1016/j.gtc.2023.08.006. Epub 2023 Oct 3.
3
4
Managing the side effects associated with commonly used treatments for bipolar depression.
J Affect Disord. 2014 Dec;169 Suppl 1:S34-44. doi: 10.1016/S0165-0327(14)70007-2.
5
[Metabolic side effects of risperidone in early onset schizophrenia].
Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1.
6
Psychiatric medication-induced obesity: a review.
Obes Rev. 2004 May;5(2):115-21. doi: 10.1111/j.1467-789X.2004.00139.x.
7
Prescription medications: a modifiable contributor to obesity.
South Med J. 1999 Sep;92(9):898-904. doi: 10.1097/00007611-199909000-00009.
8
Antipsychotic-associated weight gain: management strategies and impact on treatment adherence.
Neuropsychiatr Dis Treat. 2017 Aug 22;13:2231-2241. doi: 10.2147/NDT.S113099. eCollection 2017.
10
Weight considerations in psychotropic drug prescribing and switching.
Postgrad Med. 2013 Sep;125(5):117-29. doi: 10.3810/pgm.2013.09.2706.

引用本文的文献

1
Chronicity of obesity and the importance of early treatment to reduce cardiometabolic risk and improve body composition.
Obes Pillars. 2025 Apr 2;15:100175. doi: 10.1016/j.obpill.2025.100175. eCollection 2025 Sep.
2
Childhood Obesity: A Narrative Review.
Cureus. 2025 Apr 14;17(4):e82233. doi: 10.7759/cureus.82233. eCollection 2025 Apr.
3
Adipose Tissue Dysfunction and the Role of Adipocyte-Derived Extracellular Vesicles in Obesity and Metabolic Syndrome.
J Endocr Soc. 2024 Jun 25;8(8):bvae126. doi: 10.1210/jendso/bvae126. eCollection 2024 Jul 1.
5
Targeting inflammation in glioblastoma: An updated review from pathophysiology to novel therapeutic approaches.
Medicine (Baltimore). 2024 May 24;103(21):e38245. doi: 10.1097/MD.0000000000038245.
8
Weight Gain in Midlife Women.
Curr Obes Rep. 2024 Jun;13(2):352-363. doi: 10.1007/s13679-024-00555-2. Epub 2024 Feb 28.
9
Obesity Management in Adults: A Review.
JAMA. 2023 Nov 28;330(20):2000-2015. doi: 10.1001/jama.2023.19897.
10
Real World Use of Anti-Obesity Medications and Weight Change in Veterans.
J Gen Intern Med. 2024 Mar;39(4):519-528. doi: 10.1007/s11606-023-08501-z. Epub 2023 Nov 14.

本文引用的文献

1
Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options.
J Endocrinol Invest. 2017 Nov;40(11):1165-1174. doi: 10.1007/s40618-017-0719-6. Epub 2017 Jun 28.
4
A Post Hoc Analysis of the Effect of Weight on Efficacy in Depressed Patients Treated With Desvenlafaxine 50 mg/d and 100 mg/d.
Prim Care Companion CNS Disord. 2015 Jun 4;17(3). doi: 10.4088/PCC.14m01741. eCollection 2015.
5
Empagliflozin as adjunct to insulin in patients with type 1 diabetes: a 4-week, randomized, placebo-controlled trial (EASE-1).
Diabetes Obes Metab. 2015 Oct;17(10):928-35. doi: 10.1111/dom.12494. Epub 2015 Jun 24.
7
Dapagliflozin-induced weight loss affects 24-week glycated haemoglobin and blood pressure levels.
Diabetes Obes Metab. 2015 Aug;17(8):809-12. doi: 10.1111/dom.12500. Epub 2015 Jun 27.
9
Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis.
J Clin Endocrinol Metab. 2015 Feb;100(2):363-70. doi: 10.1210/jc.2014-3421. Epub 2015 Jan 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验